Journal Article Review Epublish 20 citations
PubMed: 38372822 DOI: 10.1007/s10571-024-01460-x
A New Strategy for the Regulation of Neuroinflammation: Exosomes Derived from Mesenchymal Stem Cells.
Cell Mol Neurobiol 44(1):24
Authors: Ying Ge, Jingjing Wu, Li Zhang, Nanqu Huang, Yong Luo
Affiliations
- Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
- Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China. Medical College of Soochow University, Suzhou, Jiangsu, China.
- National Drug Clinical Trial Institution, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
- Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Abstract
Neuroinflammation is an important pathogenesis of neurological diseases and causes a series of physiopathological changes, such as abnormal activation of glial cells, neuronal degeneration and death, and disruption of the blood‒brain barrier. Therefore, modulating inflammation may be an important therapeutic tool for treating neurological diseases. Mesenchymal stem cells (MSCs), as pluripotent stem cells, have great therapeutic potential for neurological diseases due to their regenerative ability, immunity, and ability to regulate inflammation. However, recent studies have shown that MSC-derived exosomes (MSC-Exos) play a major role in this process and play a key role in neuroprotection by regulating neuroglia. This review summarizes the recent progress made in regulating neuroinflammation by focusing on the mechanisms by which MSC-Exos are involved in the regulation of glial cells through signaling pathways such as the TLR, NF-κB, MAPK, STAT, and NLRP3 pathways to provide some references for subsequent research and therapy.
MeSH
Molecular Biology, Neurons, Therapeutics, Microscopy, Electron, Scanning Transmission, Exosomes, Neuroglia, Blood-Brain Barrier, Neurophysiology, Cell Biology, Mesenchymal Stem Cells
Cited by
- In vitro evaluation of 3D-printed conductive chitosan-polyaniline scaffolds with exosome release for enhanced angiogenesis and cardiomyocyte protection. RSC Adv, 2025
- Mechanistic insights into dental stem cells-derived exosomes in regenerative endodontics. Int Endod J, 2025
- Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair. Ocul Surf, 2024
- Identification of glutamine as a potential therapeutic target in dry eye disease. Signal Transduct Target Ther, 2025
- Natural bioactive compounds modified with mesenchymal stem cells: new hope for regenerative medicine. Front Bioeng Biotechnol, 2025
- Breaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction. Int J Mol Sci, 2025
- Induced Pluripotent Stem Cell-Derived Exosomes Promote Peripheral Nerve Regeneration in a Rat Sciatic Nerve Crush Injury Model: A Safety and Efficacy Study. Cells, 2025
- Neuroangiogenesis potential of mesenchymal stem cell extracellular vesicles in ischemic stroke conditions. Cell Commun Signal, 2025
- Targeting Neuroinflammation in Preterm White Matter Injury: Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes. Cell Mol Neurobiol, 2025